 Colin Anderson
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Maneb | 2 | 2020 | 9 | 1.220 |
Why?
| | Down Syndrome | 4 | 2022 | 522 | 0.720 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2022 | 269 | 0.690 |
Why?
| | Mitochondria | 4 | 2025 | 984 | 0.580 |
Why?
| | Pesticides | 1 | 2018 | 63 | 0.540 |
Why?
| | Glycolysis | 2 | 2019 | 341 | 0.520 |
Why?
| | Environmental Pollutants | 1 | 2018 | 143 | 0.490 |
Why?
| | Parkinson Disease | 1 | 2020 | 600 | 0.410 |
Why?
| | Thiolester Hydrolases | 2 | 2025 | 13 | 0.380 |
Why?
| | Amino Acids | 2 | 2026 | 521 | 0.350 |
Why?
| | Energy Metabolism | 3 | 2026 | 927 | 0.330 |
Why?
| | Metabolomics | 2 | 2026 | 724 | 0.310 |
Why?
| | Carbon | 2 | 2021 | 203 | 0.300 |
Why?
| | Acute Kidney Injury | 2 | 2026 | 869 | 0.270 |
Why?
| | Mevalonic Acid | 2 | 2025 | 12 | 0.270 |
Why?
| | Neuroblastoma | 2 | 2020 | 174 | 0.260 |
Why?
| | Lactoylglutathione Lyase | 2 | 2025 | 12 | 0.260 |
Why?
| | Chemokine CXCL13 | 1 | 2026 | 15 | 0.240 |
Why?
| | Azotemia | 1 | 2026 | 13 | 0.240 |
Why?
| | Lauric Acids | 1 | 2026 | 8 | 0.240 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2026 | 32 | 0.240 |
Why?
| | Cholangitis | 1 | 2026 | 22 | 0.230 |
Why?
| | Macrophages, Peritoneal | 1 | 2026 | 89 | 0.230 |
Why?
| | Polyisoprenyl Phosphates | 1 | 2025 | 4 | 0.230 |
Why?
| | Sound | 1 | 2026 | 55 | 0.230 |
Why?
| | Metabolome | 2 | 2026 | 385 | 0.230 |
Why?
| | Phosphoglycerate Dehydrogenase | 1 | 2025 | 6 | 0.220 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2026 | 141 | 0.210 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2026 | 137 | 0.210 |
Why?
| | Serine | 1 | 2025 | 142 | 0.210 |
Why?
| | Hemolysis | 1 | 2026 | 242 | 0.200 |
Why?
| | Dietary Fats | 1 | 2026 | 308 | 0.200 |
Why?
| | Cholestasis | 1 | 2026 | 213 | 0.190 |
Why?
| | Ischemia | 1 | 2026 | 422 | 0.180 |
Why?
| | Glutathione | 2 | 2026 | 366 | 0.180 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2023 | 108 | 0.180 |
Why?
| | Blood Preservation | 1 | 2026 | 345 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 532 | 0.170 |
Why?
| | Cell Line, Tumor | 4 | 2026 | 3523 | 0.170 |
Why?
| | Dinoprostone | 1 | 2021 | 180 | 0.160 |
Why?
| | Cyclooxygenase 2 | 1 | 2021 | 166 | 0.160 |
Why?
| | Mast Cells | 1 | 2021 | 148 | 0.160 |
Why?
| | Immunoglobulin E | 1 | 2021 | 315 | 0.150 |
Why?
| | Simvastatin | 1 | 2020 | 59 | 0.150 |
Why?
| | Erythrocytes | 1 | 2026 | 750 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2026 | 589 | 0.150 |
Why?
| | Cells, Cultured | 3 | 2022 | 4110 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 881 | 0.150 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.150 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 188 | 0.140 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2025 | 685 | 0.140 |
Why?
| | Diet | 1 | 2026 | 1270 | 0.130 |
Why?
| | Histones | 1 | 2023 | 663 | 0.130 |
Why?
| | Lysine | 1 | 2019 | 271 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2026 | 5967 | 0.130 |
Why?
| | Autophagy | 1 | 2019 | 284 | 0.130 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1078 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 501 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2026 | 1788 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2018 | 717 | 0.110 |
Why?
| | Fibroblasts | 1 | 2021 | 1019 | 0.110 |
Why?
| | Cell Survival | 1 | 2018 | 1092 | 0.110 |
Why?
| | Mutation | 1 | 2025 | 4081 | 0.100 |
Why?
| | Mice | 6 | 2026 | 18261 | 0.100 |
Why?
| | Humans | 13 | 2026 | 144667 | 0.090 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4539 | 0.080 |
Why?
| | Animals | 6 | 2026 | 37948 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2026 | 1338 | 0.060 |
Why?
| | Cytarabine | 1 | 2025 | 66 | 0.060 |
Why?
| | Exosomes | 1 | 2026 | 104 | 0.050 |
Why?
| | Hepatocytes | 1 | 2026 | 221 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2026 | 163 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 398 | 0.050 |
Why?
| | Acetyl Coenzyme A | 1 | 2023 | 7 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2026 | 223 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 601 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2026 | 764 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2025 | 466 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2026 | 575 | 0.040 |
Why?
| | Pyridines | 1 | 2026 | 603 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 438 | 0.040 |
Why?
| | Cyclooxygenase 1 | 1 | 2021 | 27 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 32 | 0.040 |
Why?
| | Ubiquinone | 1 | 2020 | 35 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Pyruvaldehyde | 1 | 2019 | 20 | 0.040 |
Why?
| | Male | 5 | 2026 | 72431 | 0.040 |
Why?
| | Alkynes | 1 | 2019 | 66 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2020 | 190 | 0.040 |
Why?
| | Glycosylation | 1 | 2019 | 161 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 195 | 0.030 |
Why?
| | Kidney | 1 | 2026 | 1495 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 437 | 0.030 |
Why?
| | Macrophages | 1 | 2026 | 1496 | 0.030 |
Why?
| | Liver | 1 | 2026 | 1889 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 743 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 1129 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1363 | 0.030 |
Why?
| | Skin | 1 | 2021 | 762 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 461 | 0.030 |
Why?
| | Female | 4 | 2026 | 78304 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4261 | 0.030 |
Why?
| | Inflammation | 1 | 2026 | 2870 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2022 | 2037 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2821 | 0.030 |
Why?
| | Apoptosis | 1 | 2020 | 2397 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2591 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6399 | 0.020 |
Why?
| | Infant | 1 | 2019 | 10023 | 0.010 |
Why?
|
|
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|